Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Sold Ryplazim, plasma line, collection centers
View:
Post by GunnerG on Jul 14, 2021 1:12pm

Sold Ryplazim, plasma line, collection centers

and 30% of PRV two weeks before FDA announcement.  Hmmm.  

The market sees nothing happening with this going forward.

Yes they get 70% of the PRV sale but they will blow through that quickly leaving nothing for SH.

Sold $30M of PRV asset for $5M, not sure how that is viewed as being smart.

Included in that $5M was Ryplazim and the rest of the plasma line.  So we actually gave away $30M for less $5M.  All happening two weeks before the FDA announcement.
Comment by wyndewest on Jul 14, 2021 1:35pm
Sounds underhanded; nefarious; VERY unethical to me.  Something is very wrong with the Ryplazim transaction.  Can it be prosecuted?
Comment by PLITheOne on Jul 14, 2021 1:41pm
It is very underhanded! Who in their right mind would make such a deal!? Children playing Monopoly know better how to negotiate a deal unless there is some unethical back door deals going on. Well we all know by now how Peter Thomson operates so you can be sure that he will screw investors to line his own pockets anyway he can,
Comment by GunnerG on Jul 14, 2021 2:54pm
and 30% of PRV two weeks before FDA announcement.  Hmmm.   The market sees nothing happening with this going forward. Yes they get 70% of the PRV sale but they will blow through that quickly leaving nothing for SH. Sold $30M of PRV asset for $5M, not sure how that is viewed as being smart. Included in that $5M was Ryplazim and the rest of the plasma line.  So we actually ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities